当院におけるシロリムス溶出ステントの治療成績
スポンサーリンク
概要
- 論文の詳細を見る
Many studies have shown that a sirolimus-eluting stent (SES) decreases restenosis and target leision revascularization (TLR). We investigated the outcome of SES in a general hospital in Nagano, Japan. The study group consisted of 99 patients with 127 lesions.We retrospectively evaluated the stent hrombosisand major adverse cardiac events (MACE) in the lesions of the entire study group. For evaluation of the stent and segment restenosis, follow up angiography was performed in 69 patients with 87 leisions.During follow up, a MACE occurred in 8 patients (cardiac death in 2 and TLR in 6 of 99 patients). One cardiac death was due to coronary spasm just after stent implantation, and the other to very late stent thrombosis. There were 8 segment restenoses, which included 4 stent restenoses.The outcome of SES in our hospital was comparable to that reported by other Japanese institutes. Additional research is required to avoid coronary spasm after placement of a drug-eluting stent.
- 信州医学会の論文
- 2008-10-10
著者
関連論文
- 症例 急性心筋炎を発症した筋緊張性ジストロフィーの1例
- 60) 閉塞性動脈硬化症に合併した両側膝窩動脈解離の1例(第208回日本循環器学会関東甲信越地方会)
- 当院におけるシロリムス溶出ステントの治療成績
- 91) 内腔閉塞型の肥大形態を取った肥大型心筋症末期の1例(第205回日本循環器学会関東甲信越地方会)
- 108)徐脈頻脈症候群を呈した続発性アミロイドーシスの1例(第202回日本循環器学会関東甲信越地方会)
- 86)ホルター心電図装着中に急死した異型狭心症の1症例(第201回日本循環器学会関東甲信越地方会)